The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Fosfomycin
Open accessAbstract
SUMMARY: The treatment of bacterial infections suffers from two major problems: spread of multidrug-resistant (MDR) or extensively drug-resistant (XDR) pathogens and lack of development of new antibiotics active against such MDR and XDR bacteria. As a result, physicians have turned to older antibiotics, such as polymyxins, tetracyclines, and aminoglycosides. Lately, due to development of resistance to these agents, fosfomycin has gained attention, as it has remained active against both Gram-positive and Gram-negative MDR and XDR bacteria. New data of higher quality have become available, and several issues were clarified further. In this review, we summarize the available fosfomycin data regarding pharmacokinetic and pharmacodynamic properties, the in vitro activity against susceptible and antibiotic-resistant bacteria, mechanisms of resistance and development of resistance during treatment, synergy and antagonism with other antibiotics, clinical effectiveness, and adverse events. Issues that need to be studied further are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gupta, K., Hooton, T. M., Naber, K. G., Wullt, B., Colgan, R., Miller, L. G., Moran, G. J., Nicolle, L. E., Raz, R., Schaeffer, A. J., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq257 · Cited by 3,038
Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery
Bratzler, D. W., Dellinger, E. P., Olsen, K. M., Perl, T. M., Auwaerter, P. G., Bolon, M. K., Fish, D. N., Napolitano, L. M., Sawyer, R. G., Slain, D., et al. (2013) · Surgical Infections · doi:10.1089/sur.2013.9999 · Cited by 1,197
THE MECHANISM OF ACTION OF FOSFOMYCIN (PHOSPHONOMYCIN)
Kahan, F. M., Kahan, J. S., Cassidy, P. J., & Kropp, H. (1974) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1974.tb43277.x · Cited by 777
Phosphonomycin, a New Antibiotic Produced by Strains of Streptomyces
Hendlin, D., Stapley, E. O., Jackson, M., Wallick, H., Miller, A. K., Wolf, F. J., Miller, T. W., Chaiet, L., Kahan, F. M., Foltz, E. L., et al. (1969) · Science · doi:10.1126/science.166.3901.122 · Cited by 593
Falagas, M. E., Kastoris, A. C., Kapaskelis, A. M., & Karageorgopoulos, D. E. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70325-1 · Cited by 487
Self-citationMichalopoulos, A. S., Livaditis, I. G., & Gougoutas, V. (2011) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2011.07.007 · Cited by 378
Falagas, M. E., Rafailidis, P. I., Ioannidou, E., Alexiou, V. G., Matthaiou, D. K., Karageorgopoulos, D. E., Kapaskelis, A., Nikita, D., & Michalopoulos, A. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.10.005 · Cited by 300
Self-citationSkarzynski, T., Mistry, A., Wonacott, A., Hutchinson, S. E., Kelly, V. A., & Duncan, K. (1996) · Structure · doi:10.1016/s0969-2126(96)00153-0 · Cited by 262
Kahlmeter, G., & Poulsen, H. O. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.09.013 · Cited by 256
Biological Costs and Mechanisms of Fosfomycin Resistance in Escherichia coli
Nilsson, A. I., Berg, O. G., Aspevall, O., Kahlmeter, G., & Andersson, D. I. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2850-2858.2003 · Cited by 241
Karageorgopoulos, D. E., Wang, R., Yu, X.-H., & Falagas, M. E. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr466 · Cited by 228
Self-citationPontikis, K., Karaiskos, I., Bastani, S., Dimopoulos, G., Kalogirou, M., Katsiari, M., Oikonomou, A., Poulakou, G., Roilides, E., & Giamarellou, H. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.09.010 · Cited by 220
Modulatory effect of antibiotics on cytokine production by human monocytes in vitro
Morikawa, K., Watabe, H., Araake, M., & Morikawa, S. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.6.1366 · Cited by 211
Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli
Takahata, S., Ida, T., Hiraishi, T., Sakakibara, S., Maebashi, K., Terada, S., Muratani, T., Matsumoto, T., Nakahama, C., & Tomono, K. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.11.011 · Cited by 191
Neuner, E. A., Sekeres, J., Hall, G. S., & van Duin, D. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00402-12 · Cited by 189
Samonis, G., Maraki, S., Karageorgopoulos, D. E., Vouloumanou, E. K., & Falagas, M. E. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1360-5 · Cited by 177
Self-citationCao, M., Bernat, B. A., Wang, Z., Armstrong, R. N., & Helmann, J. D. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.7.2380-2383.2001 · Cited by 167
Lee, S.-Y., Park, Y. J., Yu, J. K., Jung, S., Kim, Y., Jeong, S. H., & Arakawa, Y. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks319 · Cited by 162
French guidelines for enhanced recovery after elective colorectal surgery
Alfonsi, P., Slim, K., CHAUVIN, M., Mariani, P., Faucheron, J., & Fletcher, D. (2014) · Journal of Visceral Surgery · doi:10.1016/j.jviscsurg.2013.10.006 · Cited by 160
Falagas, M. E., Vouloumanou, E. K., Togias, A. G., Karadima, M., Kapaskelis, A. M., Rafailidis, P. I., & Athanasiou, S. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq237 · Cited by 157
Self-citationFalagas, M. E., Rafailidis, P. I., Matthaiou, D. K., Virtzili, S., Nikita, D., & Michalopoulos, A. S. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.05.016 · Cited by 154
Self-citationGiske, C. G. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.05.022 · Cited by 152
Tängdén, T., Hickman, R. A., Forsberg, P., Lagerbäck, P., Giske, C. G., & Cars, O. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00741-13 · Cited by 148
Smet, K. A. L. D., Kempsell, K. E., Gallagher, A., Duncan, K., & Young, D. B. (1999) · Microbiology · doi:10.1099/00221287-145-11-3177 · Cited by 144
Bernat, B. A., Laughlin, L. T., & Armstrong, R. N. (1997) · Biochemistry · doi:10.1021/bi963172a · Cited by 142
Eschenburg, S., Priestman, M. A., & Schönbrunn, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411325200 · Cited by 141
Briongos-Figuero, L. S., Gómez-Traveso, T., Bachiller‐Luque, P., González, M. D.-G., Gómez-Nieto, A., Palacios-Martín, T., Sagrado, M. G., Dueñas‐Laita, A., & Pérez-Castrillón, J.-L. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.02991.x · Cited by 140
Pfausler, B., Spiss, H., Dittrich, P., Zeitlinger, M., Schmutzhard, E., & Joukhadar, C. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh158 · Cited by 140
Target site penetration of fosfomycin in critically ill patients
Joukhadar, C., Klein, N., Dittrich, P., Zeitlinger, M., Geppert, A., Skhirtladze, K., Frossard, M., Heinz, G., & Müller, M. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg187 · Cited by 138
Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge
Francisco, C. N.-S., Mora-Rillo, M., Romero‐Gómez, M. P., Moreno-Ramos, F., Rico-Nieto, A., Carrascoso, G. R., Gómez-Gil, R., Arribas, J. R., Mingorance, J., & Paño‐Pardo, J. R. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12091 · Cited by 130
Trapnell, B. C., McColley, S. A., Kissner, D. G., Rolfe, M. W., Rosen, J. M., McKevitt, M. T., Moorehead, L., Montgomery, A. B., & Geller, D. E. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201105-0924oc · Cited by 129
Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms
Marchese, A. E. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00232-2 · Cited by 129
A cell wall recycling shortcut that bypasses peptidoglycan de novo biosynthesis
Gisin, J., Schneider, A., Nägele, B., Borisova, M., & Mayer, C. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1289 · Cited by 125
Miró, J. M., Entenza, J. M., del Río, A., Velasco, M., Castañeda, X., de la Mària, C. G., Giddey, M., Armero, Y., Pericàs, J. M., Cervera, C., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06449-11 · Cited by 124
Arca, P., Rico, M., Braña, A. F., Villar, C. J., Hardisson, C., & Suárez, J. E. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.10.1552 · Cited by 119
McCoy, A. J., Sandlin, R. C., & Maurelli, A. T. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.4.1218-1228.2003 · Cited by 119
Mihăilescu, R., Tafin, U. F., Corvec, S., Oliva, A., Bétrisey, B., Borens, O., & Trampuž, A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02420-12 · Cited by 119
Corvec, S., Tafin, U. F., Bétrisey, B., Borens, O., & Trampuž, A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01718-12 · Cited by 115
SAGES evidence-based guidelines for the laparoscopic resection of curable colon and rectal cancer
Zerey, M., Hawver, L. R. M., Awad, Z. T., Stefanidis, D., Richardson, W., & Fanelli, R. D. (2012) · Surgical Endoscopy · doi:10.1007/s00464-012-2592-x · Cited by 114
Is Fosfomycin a Potential Treatment Alternative for Multidrug-Resistant Gram-Negative Prostatitis?
Gardiner, B. J., Mahony, A. A., Ellis, A. G., Lawrentschuk, N., Bolton, D. M., Zeglinski, P. T., Frauman, A. G., & Grayson, M. L. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit704 · Cited by 112
Antimicrobial Activity against Intraosteoblastic Staphylococcus aureus
Valour, F., Trouillet‐Assant, S., Riffard, N., Tasse, J., Flammier, S., Rasigade, J., Chidiac, C., Vandenesch, F., Ferry, T., & Laurent, F. J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04359-14 · Cited by 108
Falagas, M. E., Ρούσσος, Ν., Gkegkes, I. D., Rafailidis, P. I., & Karageorgopoulos, D. E. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780902967624 · Cited by 106
Self-citationPurification of a glutathione S-transferase that mediates fosfomycin resistance in bacteria
Arca, P., Hardisson, C., & Suárez, J. E. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.5.844 · Cited by 105
Minassian, M. A., Lewis, D. A., Chattopadhyay, D., Bovill, B. A., Duckworth, G. J., & Williams, J. D. (1998) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(98)00021-1 · Cited by 105
MacLeod, D. L., Barker, L. M., Sutherland, J. L., Moss, S. C., Gurgel, J. L., Kenney, T. F., Burns, J. L., & Baker, W. R. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp282 · Cited by 102
High Incidence and Endemic Spread of NDM-1-Positive Enterobacteriaceae in Henan Province, China
Qin, S., Fu, Y., Zhang, Q., Qi, H., Wen, J., Xu, H., Xu, L., Zeng, L., Tian, H., Rong, L., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02813-13 · Cited by 101
Oteo, J., Orden, B., Bautista, V., Cuevas, Ó., Arroyo, M., Martínez-Ruiz, R., Pérez-Vázquez, M. D., Alcaraz, M., García-Cobos, S., & Campos, J. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp288 · Cited by 99
Falagas, M. E., Vardakas, K. Z., Tsiveriotis, K., Triarides, N. A., & Tansarli, G. S. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.01.006 · Cited by 97
Self-citationIn vitro pharmacodynamics of fosfomycin against clinical isolates of Pseudomonas aeruginosa
Walsh, C. C., McIntosh, M. P., Peleg, A. Y., Kirkpatrick, C. M. J., & Bergen, P. J. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv221 · Cited by 96
Rio, A. D., Gasch, O., Moreno, A., Pena, C., Cuquet, J., Soy, D., Mestres, C. A., Suarez, C., Paré, J. C., Tubau, F., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu580 · Cited by 92
Emergence of Fosfomycin-Resistant Isolates of Shiga-Like Toxin-Producing Escherichia coli O26
Horii, T., Kimura, T., Sato, K., Shibayama, K., & Ohta, M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.789 · Cited by 85
Rosso-Fernández, C. M., Sojo-Dorado, J., Barriga, A., Lavín-Alconero, L., Palacios-Baena, Z. R., López-Hernández, I., Merino, V., Cameán, M., Pascual, Á., Rodríguez‐Baño, J., et al. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-007363 · Cited by 79
Utsui, Y., Ohya, S., Magaribuchi, T., Tajima, M., & Yokota, T. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.6.917 · Cited by 79
Senol, S., Tasbakan, M. I., Pullukçu, H., Sipahi, O. R., Sipahi, H., Yamazhan, T., Arda, B., & Ulusoy, S. (2010) · Journal of Chemotherapy · doi:10.1179/joc.2010.22.5.355 · Cited by 78
Parker, S. L., Lipman, J., Koulenti, D., Dimοpoulos, G., & Roberts, J. A. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.05.018 · Cited by 75
Santimaleeworagun, W., Wongpoowarak, P., D, P. C. M., Pattharachayakul, S., Tansakul, P., & Garey, K. W. (2011) · PubMed · Cited by 75
Legat, F. J., Maier, A., Dittrich, P., Zenahlik, P., Kern, T., Nuhsbaumer, S., Frossard, M., Salmhofer, W., Kerl, H., & Müller, M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.371-374.2003 · Cited by 72
Falagas, M. E., Tansarli, G. S., Rafailidis, P. I., Kapaskelis, A. M., & Vardakas, K. Z. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00663-12 · Cited by 70
Self-citationIn vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae
Berçot, B., Poirel, L., Dortet, L., & Nordmann, P. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr296 · Cited by 70
Oliva, A., Tafin, U. F., Maiolo, E. M., Jeddari, S., Bétrisey, B., & Trampuž, A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02583-12 · Cited by 68
Cho, Y. H., Jung, S. I., Chung, H. S., Yu, H. S., Hwang, E. C., Kim, S., Kang, T. W., Kwon, D. D., & Park, K. (2015) · International Urology and Nephrology · doi:10.1007/s11255-015-1018-9 · Cited by 63
In vitro synergy testing of novel antimicrobial combination therapies against Neisseria gonorrhoeae
Barbee, L. A., Soge, O. O., Holmes, K. K., & Golden, M. R. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt540 · Cited by 63
Karageorgopoulos, D. E., Miriagou, V., TZOUVELEKIS, L. S., Spyridopoulou, K., & Daikos, G. L. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks270 · Cited by 60
Fosfomycin for Treatment of Prostatitis: New Tricks for Old Dogs: Figure 1.
Grayson, M. L., Maćešić, N., Trevillyan, J. M., Ellis, A. G., Zeglinski, P. T., Hewitt, N. H., Gardiner, B. J., & Frauman, A. G. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ436 · Cited by 59
Qiao, L., Zheng, B., Chen, S., Yang, Y., Zhang, K., Guo, H., Yang, B., Niu, Y., Wang, Y., Shi, B., et al. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-004157 · Cited by 58
Rebiahi, S., Abdelouahid, D. E., Rahmoun, M. N., Abdelali, S., & Azzaoui, H. (2011) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2011.09.010 · Cited by 55
Nucleotide sequence of the gene conferring fosfomycin resistance in
Zilhão, R., & Courvalin, P. M. (1990) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(05)80052-7 · Cited by 54
Evren, E., Azap, Ö. K., Çolakoğlu, Ş., & Arslan, H. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.04.004 · Cited by 54
Sahuquillo-Arce, J. M., Gaínza, E., Gil-Brusola, A., Estévez, R. O., Cantón, R., & Gobernado, M. (2006) · PubMed · Cited by 52
Tang, H.-J., Chen, C.-C., Zhang, C.-C., Su, B.-A., Li, C.-M., Weng, T., Chiang, S., Ko, W., & Chuang, Y.-C. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.07.012 · Cited by 52
Characterization of staphylococcal plasmids hybridizing with the fosfomycin resistance gene fosB
Étienne, J., Gerbaud, G., Fleurette, J., & Courvalin, P. M. (1991) · FEMS Microbiology Letters · doi:10.1016/0378-1097(91)90406-z · Cited by 52
Ceran, N., Mert, D., Kocdogan, F. Y., Erdem, İ., ÖZYÜREK, S., Göktaş, P., Adalati, R., & Ceran, N. (2010) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-010-0079-z · Cited by 51
Boerema, J. B. J., & Willems, F. T. C. (1990) · Infection · doi:10.1007/bf01643433 · Cited by 50
Shi, J., Mao, N., Wang, L., Zhang, H., Chen, Q., Liu, H., Tang, X., Jin, T., Zhu, C., Li, F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113133 · Cited by 50
Wind, C. M., de Vries, H. J. C., & van Dam, A. P. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.10.020 · Cited by 50
Karlowsky, J. A., Denisuik, A. J., Lagacé-Wiens, P. R. S., Adam, H. J., Baxter, M. R., Hoban, D. J., & Zhanel, G. G. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02399-13 · Cited by 50
Gupta, K., Hooton, T. M., & Stamm, W. E. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki169 · Cited by 49
Nakazawa, H., Kikuchi, Y., Honda, T., Isago, T., & Nozaki, M. (2003) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-003-0266-2 · Cited by 49
Sahni, R. D., Veeraraghavan, B., Varghese, R., John, J., Tansarli, G. S., & Falagas, M. E. (2013) · Future Microbiology · doi:10.2217/fmb.13.31 · Cited by 48
Self-citationBurian, A., Erdogan, Z., Jandrisits, C., & Zeitlinger, M. A. (2012) · Pharmacology · doi:10.1159/000342423 · Cited by 48
Immunosuppressive activity of fosfomycin on human T-lymphocyte function in vitro
Morikawa, K., Oseko, F., Morikawa, S., & Sawada, M. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.12.2684 · Cited by 48
Petek, M., Baebler, Š., Kuzman, D., Rotter, A., Podlesek, Z., Gruden, K., Ravnikar, M., & Urleb, U. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-159 · Cited by 47
Mavros, M. N., Tansarli, G. S., Vardakas, K. Z., Rafailidis, P. I., Karageorgopoulos, D. E., & Falagas, M. E. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.07.023 · Cited by 44
Self-citationShaw, E., Miró, J. M., Puig‐Asensio, M., Pigrau, C., Barcenilla, F., Murillas, J., García‐Pardo, G., Espejo, E., Padilla, B., García‐Reyne, A., et al. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-006723 · Cited by 43
Fosfomycin Alters Lipopolysaccharide-Induced Inflammatory Cytokine Production in Mice
Matsumoto, T., Tateda, K., Miyazaki, S., et al. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.3.697 · Cited by 42
Taj, Y., Abdullah, F. E., & Kazmi, S. U. (2010) · PubMed · Cited by 42
Engel, H., Gutiérrez‐Fernández, J., Flückiger, C., Martínez-Ripoll, M., Mühlemann, K., Hermoso, J. A., Hilty, M., & Hathaway, L. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00223-13 · Cited by 39
Zhao, J., Zhu, Y., Li, Y.-N., Mu, X.-D., You, L.-P., Cha, X., Qin, P., & Ma, J.-L. (2015) · FEMS Microbiology Letters · doi:10.1093/femsle/fnu018 · Cited by 39
In vitro activity of potential old and new drugs against multidrug-resistant gram-negatives
Rizek, C., Ferraz, J. R., van der Heijden, I. M., Giudice, M. C., Mostachio, A. K., Páez, J. I. G., Carrilho, C. M. D. D. M., Levin, A. S., & Costa, S. F. (2014) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2014.10.009 · Cited by 39
Di, X., Wang, R., Liu, B., Zhang, X., Ni, W., Wang, J., Liang, B., Cai, Y., & Liu, Y.-N. (2015) · The Journal of Antibiotics · doi:10.1038/ja.2015.27 · Cited by 39
Diez‐Aguilar, M., Morosini, M.-I., del Campo, R., García-Castillo, M., Zamora, J., & Cantón, R. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00589-13 · Cited by 34
Wei, W., Yang, H., Liu, Y., Ye, Y., & Li, J.-B. (2015) · Journal of Chemotherapy · doi:10.1179/1973947815y.0000000030 · Cited by 31
Morfín‐Otero, R., Mendoza-Olazarán, S., Silva-Sánchez, J., Rodríguez-Noriega, E., Llaca-Díaz, J. M., Tinoco, P., Petersen, L., López, P., Reyna-Flores, F., Alcántar-Curiel, M. D., et al. (2013) · Microbial Drug Resistance · doi:10.1089/mdr.2012.0263 · Cited by 30
Xu-hong, Y., Falagas, M. E., Dong, W., Karageorgopoulos, D. E., De-feng, L., & Wang, R. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2014.5 · Cited by 29
Self-citationPogue, J. M., Marchaim, D., Abreu-Lanfranco, O., Sunkara, B., Mynatt, R. P., Zhao, J., Bheemreddy, S., Hayakawa, K., Martin, E. T., Dhar, S., et al. (2013) · The Journal of Antibiotics · doi:10.1038/ja.2013.56 · Cited by 29
Trautmann, M., Meincke, C., Vogt, K., et al. (1992) · Infection · doi:10.1007/bf01710683 · Cited by 27
Hickman, R. A., Hughes, D., Cars, T., Malmberg, C., & Cars, O. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12374 · Cited by 25
Yokota, S., Okabayashi, T., Yoto, Y., Hori, T., Tsutsumi, H., & Fujii, N. (2010) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2010.02049.x · Cited by 24
McCaughey, G., Gilpin, D. F., Schneiders, T., Hoffman, L. R., McKevitt, M., Elborn, J. S., & Tunney, M. M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00750-13 · Cited by 24
Treatment of recurrent complicated urinary tract infections in children with vesicoureteral reflux
Wu, T.-H., Huang, F., Fu, L., Chou, C., Chien, Y.-L., Huang, C., Lin, C.-F., & Chen, P.-Y. (2014) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2014.08.024 · Cited by 23
In vitro Activity of Doripenem plus Fosfomycin against Drug-Resistant Clinical Blood Isolates
Lingscheid, T., Tobudic, S., Poeppl, W., Mitteregger, D., & Burgmann, H. (2013) · Pharmacology · doi:10.1159/000348572 · Cited by 22
Hirzel, C., Guilarte, Y. N., Hirzberger, L., Furrer, H., Marschall, J., & Endimiani, A. (2015) · Journal of Infection · doi:10.1016/j.jinf.2015.04.020 · Cited by 20
Immunomodulatory Effects of Fosfomycin in Experimental Human Endotoxemia
Sauermann, R., Marsik, C. L., Steiner, I. M., Seir, K., Cvitko, T., Zeitlinger, M. A., Wagner, O. F., & Joukhadar, C. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00914-06 · Cited by 19
Dubos, M., Barraud, O., Fedou, A.-L., Fredon, F., Laurent, F. J., Brakbi, Y., Cypierre, A., & François, B. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-466 · Cited by 18
Khan, I. U., Mirza, I. A., Ikram, A., Ali, S., Hussain, A., & Ghafoor, T. (2014) · PubMed · Cited by 17
Palou, J., Angulo, J. C., de Fata, F. R., García-Tello, A., Enguita, C. G., Boada, A., & Sanz, M. Á. B. (2013) · Actas Urológicas Españolas (English Edition) · doi:10.1016/j.acuroe.2012.06.006 · Cited by 16
Tigecycline for carbapenem-resistant Klebsiellapneumoniaeinfections in the intensive care unit
Vardakas, K. Z., Matthaiou, D. K., Falagas, M. E., Antypa, E., Koteli, A., & Antoniadou, E. (2015) · Scandinavian Journal of Infectious Diseases · doi:10.3109/23744235.2015.1049659 · Cited by 14
Self-citationPalou, J., Angulo, J. C., de Fata, F. R., García-Tello, A., Enguita, C. G., Boada, A., & Sanz, M. Á. B. (2012) · Actas Urológicas Españolas · doi:10.1016/j.acuro.2012.06.007 · Cited by 14
Nakamura, T., Hashimoto, I., Sawada, Y., Mikami, J., & Bekki, E. (1985) · PubMed · Cited by 8
Cited by
Antimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
Antimicrobial Resistance in Escherichia coli
Poirel, L., Madec, J.-Y., Lupo, A., Schink, A.-K., Kieffer, N., Nordmann, P., & Schwarz, S. (2018) · Microbiology Spectrum · doi:10.1128/microbiolspec.arba-0026-2017 · Cited by 876
Gehringer, M., & Laufer, S. A. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01153 · Cited by 714
Vardakas, K. Z., Voulgaris, G. L., Maliaros, A., Samonis, G., & Falagas, M. E. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30615-1 · Cited by 327
Self-citationFosfomycin: Mechanism and Resistance
Silver, L. L. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025262 · Cited by 320
Metadata
- Authors
- Falagas, M. E., Vouloumanou, E. K., Samonis, G., & Vardakas, K. Z.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2016-04
- Volume
- 29
- Issue
- 2
- Pages
- 321-347
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W4211238209
- Cited by
- 612
- References
- 110
- FWCI
- 20.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.